• Something wrong with this record ?

Two-dimensional shear wave elastography predicts survival in advanced chronic liver disease

J. Trebicka, W. Gu, V. de Ledinghen, C. Aubé, A. Krag, M. Praktiknjo, L. Castera, J. Dumortier, DJM. Bauer, M. Friedrich-Rust, S. Pol, I. Grgurevic, R. Zheng, S. Francque, H. Gottfriedovà, S. Mustapic, I. Sporea, A. Berzigotti, FE. Uschner, B....

. 2022 ; 71 (2) : 402-414. [pub] 20210121

Language English Country Great Britain

Document type Journal Article, Multicenter Study, Observational Study, Research Support, Non-U.S. Gov't

E-resources Online Full text

NLK ProQuest Central from 1960-03-01 to 6 months ago
Health & Medicine (ProQuest) from 1960-03-01 to 6 months ago

OBJECTIVE: Liver stiffness measurement (LSM) is a tool used to screen for significant fibrosis and portal hypertension. The aim of this retrospective multicentre study was to develop an easy tool using LSM for clinical outcomes in advanced chronic liver disease (ACLD) patients. DESIGN: This international multicentre cohort study included a derivation ACLD patient cohort with valid two-dimensional shear wave elastography (2D-SWE) results. Clinical and laboratory parameters at baseline and during follow-up were recorded. LSM by transient elastography (TE) was also recorded if available. The primary outcome was overall mortality. The secondary outcome was the development of first/further decompensation. RESULTS: After screening 2148 patients (16 centres), 1827 patients (55 years, 62.4% men) were included in the 2D-SWE cohort, with median liver SWE (L-SWE) 11.8 kPa and a model for end stage liver disease (MELD) score of 8. Combination of MELD score and L-SWE predict independently of mortality (AUC 0.8). L-SWE cut-off at ≥20 kPa combined with MELD ≥10 could stratify the risk of mortality and first/further decompensation in ACLD patients. The 2-year mortality and decompensation rates were 36.9% and 61.8%, respectively, in the 305 (18.3%) high-risk patients (with L-SWE ≥20 kPa and MELD ≥10), while in the 944 (56.6%) low-risk patients, these were 1.1% and 3.5%, respectively. Importantly, this M10LS20 algorithm was validated by TE-based LSM and in an additional cohort of 119 patients with valid point shear SWE-LSM. CONCLUSION: The M10LS20 algorithm allows risk stratification of patients with ACLD. Patients with L-SWE ≥20 kPa and MELD ≥10 should be followed closely and receive intensified care, while patients with low risk may be managed at longer intervals.

Bern University Hospital Bern Switzerland

CHU Bordeaux and INSERM U1053 Bordeaux University Bordeaux France

Department of Gastroenterology and Hepatology Odense University Hospital Odense Denmark

Department of Gastroenterology Hepatology Antwerp University Hospital Antwerp Belgium

Department of Hepato Gastroenterology Institute for Clinical and Experimental Medicine Prague Czech Republic

Department of Internal Medicine 1 Frankfurt University Hospital Frankfurt am Main Hessen Germany

Department of Radiology Beaujon University Hospital Clichy France

Department of Radiology Saint Jean Hospital Perpignan France

Department of Ultrasound Guangdong Key Laboratory of Liver Disease Research 3rd Affiliated Hospital of Sun Yat Sen University Guangzhou Guangdong China

Division of Gastroenterology and Hepatology Department of Internal Medicine 3 Medical University of Vienna Wien Austria

European Foundation for the Study of Chronic Liver Failure Barcelona Catalunya Spain

Fédération des Spécialités Digestives Hôpital Edouard Herriot Lyon France

Gastroenterology and Hepatology University of Medicine and Pharmacy Victor Babes Timisoara Timisoara Romania

InflaMed Centre of Excellence Translational Sciences in Inflammation and Immunology Laboratory of Experimental Medicine and Paediatrics Faculty of Medicine and Health Sciences University Hospital Antwerp Edegem Antwerp Belgium

Internal Medicine 1 University of Bonn Bonn Germany

Paris Cochin University Hopital Paris France

University Hospital and HIFIH Lab Angers France

University hospital Dubrava University of Zagreb School of Medicine Zagreb Zagreb Croatia

Zhongshan Hospital Fudan University Shanghai Shanghai China

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22011147
003      
CZ-PrNML
005      
20220506130520.0
007      
ta
008      
220425s2022 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1136/gutjnl-2020-323419 $2 doi
035    __
$a (PubMed)33479052
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Trebicka, Jonel $u Department of Internal Medicine I, Frankfurt University Hospital, Frankfurt am Main, Hessen, Germany Jonel.Trebicka@kgu.de $u European Foundation for the Study of Chronic Liver Failure, Barcelona, Catalunya, Spain $1 https://orcid.org/0000000270283881
245    10
$a Two-dimensional shear wave elastography predicts survival in advanced chronic liver disease / $c J. Trebicka, W. Gu, V. de Ledinghen, C. Aubé, A. Krag, M. Praktiknjo, L. Castera, J. Dumortier, DJM. Bauer, M. Friedrich-Rust, S. Pol, I. Grgurevic, R. Zheng, S. Francque, H. Gottfriedovà, S. Mustapic, I. Sporea, A. Berzigotti, FE. Uschner, B. Simbrunner, M. Ronot, C. Cassinotto, M. Kjaergaard, F. Andrade, M. Schulz, G. Semmler, IT. Drinkovic, J. Chang, MJ. Brol, PE. Rautou, T. Vanwolleghem, CP. Strassburg, J. Boursier, PG. Ferstl, DN. Rasmussen, T. Reiberger, V. Vilgrain, A. Guibal, O. Guillaud, S. Zeuzem, C. Vassord, X. Lu, L. Vonghia, R. Senkerikova, A. Popescu, C. Margini, W. Wang, M. Thiele, C. Jansen
520    9_
$a OBJECTIVE: Liver stiffness measurement (LSM) is a tool used to screen for significant fibrosis and portal hypertension. The aim of this retrospective multicentre study was to develop an easy tool using LSM for clinical outcomes in advanced chronic liver disease (ACLD) patients. DESIGN: This international multicentre cohort study included a derivation ACLD patient cohort with valid two-dimensional shear wave elastography (2D-SWE) results. Clinical and laboratory parameters at baseline and during follow-up were recorded. LSM by transient elastography (TE) was also recorded if available. The primary outcome was overall mortality. The secondary outcome was the development of first/further decompensation. RESULTS: After screening 2148 patients (16 centres), 1827 patients (55 years, 62.4% men) were included in the 2D-SWE cohort, with median liver SWE (L-SWE) 11.8 kPa and a model for end stage liver disease (MELD) score of 8. Combination of MELD score and L-SWE predict independently of mortality (AUC 0.8). L-SWE cut-off at ≥20 kPa combined with MELD ≥10 could stratify the risk of mortality and first/further decompensation in ACLD patients. The 2-year mortality and decompensation rates were 36.9% and 61.8%, respectively, in the 305 (18.3%) high-risk patients (with L-SWE ≥20 kPa and MELD ≥10), while in the 944 (56.6%) low-risk patients, these were 1.1% and 3.5%, respectively. Importantly, this M10LS20 algorithm was validated by TE-based LSM and in an additional cohort of 119 patients with valid point shear SWE-LSM. CONCLUSION: The M10LS20 algorithm allows risk stratification of patients with ACLD. Patients with L-SWE ≥20 kPa and MELD ≥10 should be followed closely and receive intensified care, while patients with low risk may be managed at longer intervals.
650    _2
$a dospělí $7 D000328
650    _2
$a algoritmy $7 D000465
650    _2
$a chronická nemoc $7 D002908
650    12
$a elastografie $7 D054459
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a nemoci jater $x diagnóza $x etiologie $x mortalita $7 D008107
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a prediktivní hodnota testů $7 D011237
650    _2
$a ROC křivka $7 D012372
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a míra přežití $7 D015996
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a pozorovací studie $7 D064888
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Gu, Wenyi $u Department of Internal Medicine I, Frankfurt University Hospital, Frankfurt am Main, Hessen, Germany $1 https://orcid.org/0000000216156064
700    1_
$a de Ledinghen, Victor $u CHU Bordeaux and INSERM U1053, Bordeaux University, Bordeaux, France
700    1_
$a Aubé, Christophe $u University Hospital and HIFIH Lab (UE3859), Angers, France
700    1_
$a Krag, Aleksander $u Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark
700    1_
$a Praktiknjo, Michael $u Internal Medicine I, University of Bonn, Bonn, Germany $1 https://orcid.org/0000000170339956
700    1_
$a Castera, Laurent $u Department of Radiology, Beaujon University Hospital, Clichy, France
700    1_
$a Dumortier, Jerome $u Fédération des Spécialités Digestives, Hôpital Edouard Herriot, Lyon, France
700    1_
$a Bauer, David Josef Maria $u Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Wien, Austria
700    1_
$a Friedrich-Rust, Mireen $u Department of Internal Medicine I, Frankfurt University Hospital, Frankfurt am Main, Hessen, Germany
700    1_
$a Pol, Stanislas $u Paris Cochin University Hopital, Paris, France
700    1_
$a Grgurevic, Ivica $u University hospital Dubrava, University of Zagreb School of Medicine, Zagreb, Zagreb, Croatia
700    1_
$a Zheng, Rongqin $u Department of Ultrasound, Guangdong Key Laboratory of Liver Disease Research, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China
700    1_
$a Francque, Sven $u InflaMed Centre of Excellence, Translational Sciences in Inflammation and Immunology, Laboratory of Experimental Medicine and Paediatrics, Faculty of Medicine and Health Sciences, University Hospital Antwerp, Edegem, Antwerp, Belgium $u Department of Gastroenterology Hepatology, Antwerp University Hospital, Antwerp, Belgium $1 https://orcid.org/0000000275274714
700    1_
$a Gottfriedovà, Halima $u Department of Hepato-Gastroenterology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Mustapic, Sanda $u University hospital Dubrava, University of Zagreb School of Medicine, Zagreb, Zagreb, Croatia
700    1_
$a Sporea, Ioan $u Gastroenterology and Hepatology, University of Medicine and Pharmacy Victor Babes Timisoara, Timisoara, Romania
700    1_
$a Berzigotti, Annalisa $u Bern University Hospital, Bern, Switzerland
700    1_
$a Uschner, Frank Erhard $u Department of Internal Medicine I, Frankfurt University Hospital, Frankfurt am Main, Hessen, Germany $1 https://orcid.org/0000000237602887
700    1_
$a Simbrunner, Benedikt $u Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Wien, Austria
700    1_
$a Ronot, Maxime $u Department of Radiology, Beaujon University Hospital, Clichy, France
700    1_
$a Cassinotto, Christophe $u University Hospital and HIFIH Lab (UE3859), Angers, France $1 https://orcid.org/0000000151364742
700    1_
$a Kjaergaard, Maria $u Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark
700    1_
$a Andrade, Filipe $u Department of Radiology, Beaujon University Hospital, Clichy, France
700    1_
$a Schulz, Martin $u Department of Internal Medicine I, Frankfurt University Hospital, Frankfurt am Main, Hessen, Germany
700    1_
$a Semmler, Georg $u Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Wien, Austria
700    1_
$a Drinkovic, Ida Tjesic $u University hospital Dubrava, University of Zagreb School of Medicine, Zagreb, Zagreb, Croatia
700    1_
$a Chang, Johannes $u Internal Medicine I, University of Bonn, Bonn, Germany
700    1_
$a Brol, Maximilian Joseph $u Department of Internal Medicine I, Frankfurt University Hospital, Frankfurt am Main, Hessen, Germany
700    1_
$a Rautou, Pierre Emmanuel $u Department of Radiology, Beaujon University Hospital, Clichy, France
700    1_
$a Vanwolleghem, Thomas $u InflaMed Centre of Excellence, Translational Sciences in Inflammation and Immunology, Laboratory of Experimental Medicine and Paediatrics, Faculty of Medicine and Health Sciences, University Hospital Antwerp, Edegem, Antwerp, Belgium $u Department of Gastroenterology Hepatology, Antwerp University Hospital, Antwerp, Belgium
700    1_
$a Strassburg, Christian P $u Internal Medicine I, University of Bonn, Bonn, Germany
700    1_
$a Boursier, Jerome $u University Hospital and HIFIH Lab (UE3859), Angers, France $1 https://orcid.org/0000000272821436
700    1_
$a Ferstl, Philip Georg $u Department of Internal Medicine I, Frankfurt University Hospital, Frankfurt am Main, Hessen, Germany
700    1_
$a Rasmussen, Ditlev Nytoft $u Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark
700    1_
$a Reiberger, Thomas $u Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Wien, Austria $1 https://orcid.org/0000000245903583
700    1_
$a Vilgrain, Valerie $u Department of Radiology, Beaujon University Hospital, Clichy, France
700    1_
$a Guibal, Aymeric $u Department of Radiology, Saint Jean Hospital, Perpignan, France
700    1_
$a Guillaud, Olivier $u Fédération des Spécialités Digestives, Hôpital Edouard Herriot, Lyon, France
700    1_
$a Zeuzem, Stefan $u Department of Internal Medicine I, Frankfurt University Hospital, Frankfurt am Main, Hessen, Germany
700    1_
$a Vassord, Camille $u Paris Cochin University Hopital, Paris, France
700    1_
$a Lu, Xue $u Department of Ultrasound, Guangdong Key Laboratory of Liver Disease Research, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China
700    1_
$a Vonghia, Luisa $u InflaMed Centre of Excellence, Translational Sciences in Inflammation and Immunology, Laboratory of Experimental Medicine and Paediatrics, Faculty of Medicine and Health Sciences, University Hospital Antwerp, Edegem, Antwerp, Belgium $u Department of Gastroenterology Hepatology, Antwerp University Hospital, Antwerp, Belgium
700    1_
$a Senkerikova, Renata $u Department of Hepato-Gastroenterology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Popescu, Alina $u Gastroenterology and Hepatology, University of Medicine and Pharmacy Victor Babes Timisoara, Timisoara, Romania
700    1_
$a Margini, Cristina $u Bern University Hospital, Bern, Switzerland
700    1_
$a Wang, Wenping $u Zhongshan Hospital Fudan University, Shanghai, Shanghai, China
700    1_
$a Thiele, Maja $u Department of Gastroenterology and Hepatology, Odense University Hospital, Odense, Denmark $1 https://orcid.org/0000000318541924
700    1_
$a Jansen, Chrisitan $u Internal Medicine I, University of Bonn, Bonn, Germany
773    0_
$w MED00009778 $t Gut $x 1468-3288 $g Roč. 71, č. 2 (2022), s. 402-414
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33479052 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506130512 $b ABA008
999    __
$a ok $b bmc $g 1788969 $s 1162345
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 71 $c 2 $d 402-414 $e 20210121 $i 1468-3288 $m Gut $n Gut $x MED00009778
LZP    __
$a Pubmed-20220425

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...